A Phase II Study of Frontline Paclitaxel/Carboplatin/Bevacizumab, Paclitaxel/Carboplatin/Temsirolimus, or Ixabepilone/Carboplatin/Bevacizumab in Advanced/Recurrent Endometrial Cancer

OBJECTIVE: Paclitaxel and carboplatin (PC) is a standard initial therapy for advanced endometrial cancer. We evaluated the efficacy and tolerability of incorporating three novel agents into initial therapy. METHODS: In this randomized phase II trial, patients with chemotherapy-naive stage 11I/IVA (w...

詳細記述

保存先:
書誌詳細
出版年:Gynecol Oncol
主要な著者: Aghajanian, Carol, Filiaci, Virginia, Dizon, Don S., Carlson, Jay W., Powell, Matthew A., Alvarez Secord, Angeles, Tewari, Krishnansu S., Bender, David P., O’Malley, David M., Stuckey, Ashley, Gao, JianJiong, Dao, Fanny, Soslow, Robert A., Lankes, Heather A., Moore, Kathleen, Levine, Douglas A.
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6179372/
https://ncbi.nlm.nih.gov/pubmed/29804638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.05.018
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料